The first edition of the DeciBio Bioprocessing Market Report (2024–2027) provides a comprehensive overview and forward-looking analysis of the global bioprocessing market, focusing on the tools, technologies, and services that enable the production of therapeutic products through biological processes. It covers both manufacturer and CDMO (Contract Development Manufacturing Organization) markets, presenting market size, growth forecasts, drivers, barriers, and key industry trends. The report is segmented by modality (e.g., monoclonal antibodies, cell and gene therapies, vaccines, peptides), product type, workflow step, and customer type, and features detailed competitive landscape profiles for top vendors. Quantitative analysis is informed by extensive primary research, including 23 expert interviews, and secondary research, providing insights for potential strategic planning, investment, and partnership decisions in the bioprocessing space.
See more details below.